Dami & Xiaomi
Shenzhen, China · Founded 2014 · $62.6M raised
- Headquarters
- Shenzhen
- Employees
- 201–500
- Founded
- 2014
- Business Model
- B2C
- Total Funding
- $62.6M
- Last Round
- $42.0M Series DJul 2022
- Rounds
- 4
About
Dami & Xiaomi is China's leading provider of early intervention and rehabilitation services for children aged 3–12 diagnosed with Autism Spectrum Disorder (ASD), founded in 2014 and headquartered in Shenzhen. The company operates a nationwide network of therapy centers across 30 locations in 14 major Tier 1 and 2 Chinese cities, offering 1-to-1 behavioral therapy based on Applied Behavior Analysis (ABA) alongside online and offline training programs for parents and caregivers. In 2024, Dami & Xiaomi partnered with Amazon Web Services to launch RICE AI, an AI-powered solution extending therapy access to more children and families across China.
Summary
Dami & Xiaomi is an Education company based in Shenzhen, China, founded in 2014. It has raised $62.6M in total across 4 rounds, most recently a $42.0M Series D round in Jul 2022. Investors include Grand Flight Investment, ABC Impact and OrbiMed.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2022
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
A platform comprised of two businesses with a mission of elevating the student experience through...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
